1143 related articles for article (PubMed ID: 27276368)
21. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.
Sarr MG; Hamilton SR; Marrone GC; Cameron JL
Am J Surg; 1985 Jan; 149(1):187-93. PubMed ID: 3966636
[TBL] [Abstract][Full Text] [Related]
22. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
23. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
[TBL] [Abstract][Full Text] [Related]
24. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
26. Screening for Barrett's esophagus.
Zakko L; Lutzke L; Wang KK
Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
[TBL] [Abstract][Full Text] [Related]
27. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
28. Focus on Barrett's esophagus and esophageal adenocarcinoma.
Paulson TG; Reid BJ
Cancer Cell; 2004 Jul; 6(1):11-6. PubMed ID: 15261138
[No Abstract] [Full Text] [Related]
29. Natural history of Barrett's esophagus.
Milind R; Attwood SE
World J Gastroenterol; 2012 Jul; 18(27):3483-91. PubMed ID: 22826612
[TBL] [Abstract][Full Text] [Related]
30. Is Obesity Associated with Barrett's Esophagus and Esophageal Adenocarcinoma?
Lynch KL
Gastroenterol Clin North Am; 2016 Dec; 45(4):615-624. PubMed ID: 27837776
[TBL] [Abstract][Full Text] [Related]
31. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of gastroesophageal reflux disease/Barrett's esophagus.
D'Cunha J; Andrade RS; Maddaus MA
Minerva Chir; 2011 Feb; 66(1):7-19. PubMed ID: 21389921
[TBL] [Abstract][Full Text] [Related]
33. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
Schneider JL; Corley DA
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):353-364. PubMed ID: 28577761
[TBL] [Abstract][Full Text] [Related]
34. Barrett's esophagus. Reducing the risk of progression to adenocarcinoma.
Reynolds JC; Waronker M; Pacquing MS; Yassin RR
Gastroenterol Clin North Am; 1999 Dec; 28(4):917-45. PubMed ID: 10695010
[TBL] [Abstract][Full Text] [Related]
35. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
Duhaylongsod FG; Wolfe WG
J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
[TBL] [Abstract][Full Text] [Related]
36. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
Kim R; Weissfeld JL; Reynolds JC; Kuller LH
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
[TBL] [Abstract][Full Text] [Related]
37. Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study.
Thota PN; Hajifathalian K; Benjamin T; Runkana A; Lopez R; Sanaka MR
J Dig Dis; 2017 Mar; 18(3):143-150. PubMed ID: 28188977
[TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
39. Molecular biology of Barrett's cancer.
Atherfold PA; Jankowski JA
Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
[TBL] [Abstract][Full Text] [Related]
40. [Medical treatment of Barrett's esophagus].
Kinoshita Y; Yuki T
Nihon Rinsho; 2005 Aug; 63(8):1449-53. PubMed ID: 16101238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]